Verve Therapeutics
VERV
#6544
Rank
S$0.70 B
Marketcap
$8.37
Share price
-0.79%
Change (1 day)
-61.67%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -S$0.3 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are S$20.64 Million. In 2023 the company made an earning of -S$0.3 Billion a decrease over its 2022 earnings that were of -S$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.3 Billion1.16%
2023 -S$0.3 Billion34.67%
2022 -S$0.22 Billion90.3%
2021 -S$0.12 Billion114.31%
2020 -S$53.87 Million